Ocrevus, Rituxan & Kesimpta: How They Work and When to Use Them
New Section
This section introduces the topic of B cell depleting drugs and their effectiveness in treating multiple sclerosis. The speaker aims to explain how these drugs work.
Introduction to B Cell Depleting Drugs
- B cell depleting drugs like Ocrevus, Kesimpta, Rituximab, and Ublituximab are effective medicines used to treat multiple sclerosis (MS).
- These drugs target B cells, which play a significant role in causing damage in MS.
- In this video, the speaker will explain how B cell depletors like Ocrevus work.
New Section
The speaker encourages viewers to continue watching the video for an explanation of how B-cell medicines work in treating multiple sclerosis.
New Section
The speaker discusses the misconception that MS only involves T cells and highlights the significant role of B cells in causing damage in MS.
Role of B Cells in Multiple Sclerosis
- The humoral component of the immune system includes B cells, which play a significant role in causing damage in MS.
- Medicines that deplete B cells, such as Ocrevus (Ocrelizumab), Kesimpta (Ublituximab), and Rituximab, are highly effective in treating MS.
New Section
The speaker explains what a B cell is before diving into how B-cell depleters work.
Understanding B Cells
- B cells are part of the adaptive immune system.
- The immune system has two halves - innate and adaptive. This discussion focuses on the adaptive immune response.
- Adaptive immune cells, including B cells and T cells, are born in the bone marrow.
- B cells fully mature in the bone marrow and have various roles in the immune system.
New Section
The speaker explains the adaptive immune response and its ability to learn and evolve over time.
Adaptive Immune Response
- The adaptive immune response is called "adaptive" because it can learn and evolve.
- Initially, adaptive immune cells are undifferentiated but mature into specific responses targeting particular threats.
- T cells and B cells are two components of the adaptive immune response.
- T cells have been studied extensively in MS as they directly attack myelin, causing damage.
- However, recent understanding reveals the significant role of B cells in MS.
New Section
The speaker discusses the maturation process of B and T cells, highlighting their respective locations (bone marrow and thymus).
Maturation of B and T Cells
- Adaptive immune cells start their journey in the bone marrow.
- Some cells leave the bone marrow to travel to the thymus for maturation. These become T cells (T for thymus).
- Other cells stay in the bone marrow until they fully mature, becoming B cells (B for bone marrow).
New Section
The speaker explains one of the key functions of B cells - antibody production.
Role of B Cells
- One important function of B cells is antibody production.
- When exposed to a target (e.g., through vaccination), B cells produce antibodies that can recognize and neutralize infections upon subsequent exposure.
New Section
The speaker discusses how B cell-T cell interaction plays a role in multiple sclerosis and introduces an analogy to explain the relationship.
B Cell-T Cell Interaction
- B cells play a crucial role in stimulating T cells to fight against threats through co-stimulation.
- The speaker uses an analogy from high school, where friends encourage someone to fight, to illustrate the importance of B cell-T cell interaction.
- In MS, B cells are required to stimulate and co-stimulate T cells for an effective immune response.
New Section
The speaker concludes the video by emphasizing the significance of B cells in MS and encourages viewers to like, subscribe, and share the content.
Conclusion
- Understanding the role of B cells in MS is essential for developing effective treatments.
- B cell depleting drugs have shown great efficacy in treating MS by targeting these key players in the immune system.
- Liking, subscribing, and sharing the video helps reach more people impacted by MS.
New Section
This section discusses the effectiveness of B-cell depleting medicines in treating certain conditions and how they work.
How B-cell Depleters Work
- B-cell depleting medicines, such as Okrivis, Cassempta, and Rituxan, are monoclonal antibodies that specifically target adult B cells.
- These medicines act like biologic keys that bind to adult B cells and tag them for death. They call over complement friends to make the B cells die.
- The stem cells responsible for producing new B cells are not affected by these medications, so the therapy needs to be repeated periodically.
Maintaining Immunity
- B-cell depleting medicines do not affect plasma cells, which are responsible for producing antibodies against viruses like COVID-19.
- Existing immunity from vaccines or previous infections is maintained even after starting B-cell depletion therapy. It is important to ensure all vaccines are up to date before starting this treatment.
Effectiveness in Treating Multiple Sclerosis
- B-cell depleting medicines have shown great efficacy in treating multiple sclerosis (MS). They are considered some of the most effective medications for MS treatment.
The transcript was provided in English language, so the summary and study notes were also written in English using markdown format.